MethylScan is a low-cost blood test that detects multiple cancers and liver diseases by analyzing DNA methylation patterns ...
Lung cancer remains the leading cause of cancer-related deaths worldwide, accounting for nearly one in five cancer deaths – ...
DELFI Diagnostics to showcase whole-genome cfDNA platform advances in cancer detection and monitoring at AACR 2026 meeting: Palo Alto, California Wednesday, April 8, 2026, 15:00 H ...
Lung cancer remains the leading cause of cancer-related deaths worldwide, accounting for nearly one in five cancer deaths - around 1.8 million lives lost each year.
New cfDNA test enables multicancer detection with high accuracy, offering a cost effective approach for early diagnosis and screening.
Scientists have developed a simple and cost-effective blood test that shows promise for detecting multiple cancers, various ...
April 9, 2026 - By Denise Heady - UCLA scientists have developed a simple and cost-effective blood test that, in early ...
Caris AI Insights are proprietary and only available to Caris Life Sciences customers IRVING, Texas, April 8, 2026 ...
MethylScan is a new low-cost cell-free DNA methylome test that removes much of the healthy blood DNA background, helping rare ...
Integration Will Enable Approximately 450 Health Systems to Access the Galleri Test Results Within Their Existing Patient Portal. Collaboration With Epic Will Allow Clinicians to ...
Lung cancer remains the leading cause of cancer-related deaths worldwide, accounting for nearly one in five cancer deaths – ...
JPMorgan CEO Jamie Dimon told shareholders AI is transformational, predicting breakthroughs in medicine and massive ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results